HEMORRHAGIC CEREBROSPINAL FLUID NEURAL STEM CELLS

Patent number:

PCT/EP2019/063888; US 17/059,083; EP 19726702.4

Andalucía.svg
No items found.

The present invention provides a novel method to isolate neural stem cells (NSCs) from the cerebrospinal fluid (CSF) of preterm infants with intraventricular haemorrhage (IVH) suitable as advanced therapy for the autologous treatment of infants with IVH or for developing allogeneic therapies for different neurological disorders.

Countries:
Spain
Regions:
Andalusia
Centers:
SERVICIO ANDALUZ DE SALUD, UNIVERSIDAD DE MALAGA, FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD
Other entities:
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

1. CSF-NSCs are directly isolated from discarded liquid obtained during neuroendoscopic irrigation performed as treatment of PHH, so pose no ethical concerns. 2. CSF-NSCs are phenotypically stable through passages and adequately proliferate maintaining a stable karyotype. 3. Gene-expression profile of our cells is closer to foetal NSCs than to IPS-derived NSCs, bone marrow mesenchymal or cord blood hematopoietic stem cells. However, CSF-NSCs overexpress 112 markers that differentiate them from foetal NSCs which can be useful to isolate them. 4. Fibroblast-like cells can be isolated from these samples meaning that non-hemorragic CSF can be a new source for fibroblast/mesenchymal stem cells isolation.

Comments

Other related patents

Health

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS

Countries
Spain
Know more
Health

COMPOSITION FOR THE PREVENTION AND TREATMENT OF IRON DEFICIECY AND ANEMIA.

Countries
Spain
Know more
Health
Medical Devices
Digital Health

SENSORY MEDICAL DEVICE WITH EXPANDED FEATURES

Countries
Spain
Know more
Get back to patents directory